Sandu Pharmaceuticals Limited
SANDUPHQ.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$352.24M
Close$
$22.70
35.4% downside
Current Fair Value
35.4% downsideOvervalued by 35.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $352.24 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $1.00 (2.74%) |
| Earnings per Share | $1.83 |
| Beta | 0.36 |
| Outstanding Shares | 9,660,990 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 19.92 |
|---|---|
| PEG | 907.94 |
| Price to Sales | 0.49 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Sandu Pharmaceuticals Limited
258 employees
CEO: Balaram Viswanathan Sandu Pharmaceuticals Limited specializes in the production and distribution of traditional Ayurvedic remedies. The company's extensive product line features various well-known brands, including Berbenteron (available as both suspension ...